XBiotech Inc.

Xbiotech Inc.

Biotechnology Healthcare Austin, TX, United States XBIT (NMS)

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has XBiotech Inc. had layoffs?
No layoff events have been recorded for XBiotech Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does XBiotech Inc. have?
XBiotech Inc. has approximately 88 employees.
What industry is XBiotech Inc. in?
XBiotech Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is XBiotech Inc. a publicly traded company?
Yes, XBiotech Inc. is publicly traded under the ticker symbol XBIT on the NMS. The company has a market capitalization of approximately $0.08 billion.
Where is XBiotech Inc. headquartered?
XBiotech Inc. is headquartered in Austin, TX, United States at 5217 Winnebago Lane, Austin, TX 78744, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.